SI-BONE Inc. (SIBN) reported first-quarter 2026 revenue of $52.6 million, up 11.2% year-over-year, and gross profit of $41.9 million (+11.3% year-over-year).
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
SI-BONE Inc. Insider Trading Activity
SI-BONE Inc. insiders have traded $SIBN stock on the open market 62 times in the past 6 months. Of those trades, 0 have been purchases and 62 have been sales.
Here’s a breakdown of recent trading of $SIBN stock by insiders over the last 6 months:
- JEFFREY W DUNN has made 0 purchases and 7 sales selling 120,674 shares for an estimated $2,338,063.
- LAURA FRANCIS (Chief Executive Officer) has made 0 purchases and 14 sales selling 115,638 shares for an estimated $1,817,813.
- ANSHUL MAHESHWARI (Chief Financial Officer) has made 0 purchases and 16 sales selling 55,978 shares for an estimated $983,937.
- MICHAEL A. PISETSKY (SVP, Ops & Adm/Chief Legal Ofr) has made 0 purchases and 15 sales selling 50,678 shares for an estimated $887,865.
- ANTHONY J RECUPERO has made 0 purchases and 9 sales selling 28,559 shares for an estimated $463,179.
- MIKA NISHIMURA sold 4,100 shares for an estimated $56,700
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
SI-BONE Inc. Hedge Fund Activity
We have seen 93 institutional investors add shares of SI-BONE Inc. stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST LIGHT ASSET MANAGEMENT, LLC added 3,115,001 shares (+162.4%) to their portfolio in Q4 2025, for an estimated $61,427,819
- ORBIMED ADVISORS LLC removed 2,578,979 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $50,857,465
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 992,762 shares (-47.1%) from their portfolio in Q4 2025, for an estimated $19,577,266
- CADIAN CAPITAL MANAGEMENT, LP added 576,100 shares (+96.8%) to their portfolio in Q4 2025, for an estimated $11,360,692
- AMERICAN CENTURY COMPANIES INC removed 537,599 shares (-18.9%) from their portfolio in Q4 2025, for an estimated $10,601,452
- GILDER GAGNON HOWE & CO LLC added 413,958 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,163,251
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 363,142 shares (-80.9%) from their portfolio in Q4 2025, for an estimated $7,161,160
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
SI-BONE Inc. Analyst Ratings
Wall Street analysts have issued reports on $SIBN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- Needham issued a "Buy" rating on 12/16/2025
To track analyst ratings and price targets for SI-BONE Inc., check out Quiver Quantitative's $SIBN forecast page.
SI-BONE Inc. Price Targets
Multiple analysts have issued price targets for $SIBN recently. We have seen 7 analysts offer price targets for $SIBN in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Samuel Brodovsky from Truist Securities set a target price of $20.0 on 04/15/2026
- Mathew Blackman from TD Cowen set a target price of $22.0 on 02/24/2026
- Caitlin Roberts from Canaccord Genuity set a target price of $27.0 on 12/17/2025
- David Saxon from Needham set a target price of $27.0 on 12/16/2025
- Drew Ranieri from Morgan Stanley set a target price of $23.0 on 12/02/2025
